Eptifab 75/100 (Eptifibatide Vials) 75mg/100ml

Eptifab 75/100 contains eptifibatide, a glycoprotein IIb/IIIa inhibitor used in hospital settings. This vial form is designed for intravenous administration in acute coronary care. Store between 2-8°C to maintain potency. Always consult a healthcare professional before use.

Strength

75mg/100ml

Pack Size

1's

Storage

2-8°

Manufacturer / TM Owner

Abbott Healthcare Pvt Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Eptifab 75/100 is used to prevent blood clots during certain heart-related procedures like angioplasty. It belongs to a class of medications that help reduce the risk of complications in patients with unstable angina or those undergoing percutaneous coronary intervention. This medication works by preventing platelets in the blood from sticking together. It is typically administered in a controlled medical environment.

Side Effects

Eptifab 75/100 may cause mild to moderate effects such as headache, nausea, or dizziness. Some patients may experience bruising or bleeding at the injection site. These effects are usually temporary and monitored closely during treatment. The medication’s action helps maintain blood flow to the heart during critical procedures.

Precautions & Warnings

Eptifab 75/100 should only be handled and administered by trained medical professionals. Patients with a history of bleeding disorders or recent surgery should inform their doctor before use. Regular monitoring of blood counts and clotting parameters is essential during treatment. Avoid sudden movements or activities that may increase bleeding risk.

Avoid Interactions

Eptifab 75/100 may interact with other blood thinners, NSAIDs, or medications that affect platelet function. Combining it with certain drugs could increase the risk of bleeding. Always disclose all medications, including over-the-counter products, to your healthcare provider. Alcohol and herbal supplements should also be discussed.

References

Frequently Asked Questions

Eptifab 75/100 is used to prevent blood clots during heart procedures like angioplasty.

It is given intravenously by healthcare professionals in a clinical setting.

Common effects include headache, nausea, or bruising at the injection site.

No, it is only administered in a hospital or supervised medical environment.

Inform your doctor about bleeding disorders, recent surgeries, or other medications.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.